Law360, New York (September 23, 2014, 7:44 PM EDT) -- The Florida federal judge overseeing the multidistrict litigation over the inflammatory bowel disease risks of acne medication Accutane on Tuesday granted Hoffmann-La Roche Ltd.'s summary judgment bid in one of three remaining suits in the MDL, dismissing the plaintiff's claims that its warning was inadequate.
U.S. District Judge James Moody granted Roche's summary judgment motion in a suit brought by plaintiff Karly Greenshields, finding that a post-2000 warning label on the acne medication was adequate under California law. The ruling leaves only two cases remaining in the federal MDL, but could have an effect on the more than 7,300 cases in...
Stay ahead of the curve
In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.
Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
Create custom alerts for specific article and case topics and so much more!